RTOG 0525: A randomized phase III trial comparing standard adjuvant temozolomide (TMZ) with a dose-dense (dd) schedule in newly diagnosed glioblastoma (GBM).

RTOG 0525: A randomized phase III trial comparing standard adjuvant temozolomide (TMZ) with a dose-dense (dd) schedule in newly diagnosed glioblastoma (GBM). Other Scholarly Work

Gilbert, MR, Wang, M, Aldape, KD et al. (2011). RTOG 0525: A randomized phase III trial comparing standard adjuvant temozolomide (TMZ) with a dose-dense (dd) schedule in newly diagnosed glioblastoma (GBM). . JOURNAL OF CLINICAL ONCOLOGY, 29(15), 10.1200/jco.2011.29.15_suppl.2006

International Collaboration

cited authors

Gilbert, MR; Wang, M; Aldape, KD; Stupp, R; Hegi, M; Jaeckle, KA; Armstrong, TS; Wefel, JS; Won, M; Blumenthal, DT; Mahajan, A; Schultz, CJ; Erridge, SC; Brown, PD; Chakravarti, A; Curran, WJ; Mehta, MP